Barclays’s Zentalis Pharmaceuticals ZNTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $0 | Sell |
1
-59,615
| -100% | – | ﹤0.01% | 4622 |
|
|
2025
Q1 | $95K | Sell |
59,616
-57,779
| -49% | -$92.1K | ﹤0.01% | 3710 |
|
|
2024
Q4 | $355K | Buy |
117,395
+42,000
| +56% | +$127K | ﹤0.01% | 3244 |
|
|
2024
Q3 | $277K | Buy |
75,395
+11,748
| +18% | +$43.2K | ﹤0.01% | 3326 |
|
|
2024
Q2 | $261K | Sell |
63,647
-2,670
| -4% | -$10.9K | ﹤0.01% | 2903 |
|
|
2024
Q1 | $1.05M | Sell |
66,317
-153,201
| -70% | -$2.41M | ﹤0.01% | 2377 |
|
|
2023
Q4 | $3.33M | Buy |
219,518
+108,701
| +98% | +$1.65M | ﹤0.01% | 1797 |
|
|
2023
Q3 | $2.22M | Sell |
110,817
-101,598
| -48% | -$2.04M | ﹤0.01% | 1606 |
|
|
2023
Q2 | $5.99M | Buy |
212,415
+122,451
| +136% | +$3.45M | ﹤0.01% | 1136 |
|
|
2023
Q1 | $1.55M | Sell |
89,964
-37,910
| -30% | -$652K | ﹤0.01% | 1831 |
|
|
2022
Q4 | $2.58M | Buy |
127,874
+11,276
| +10% | +$227K | ﹤0.01% | 1486 |
|
|
2022
Q3 | $2.53M | Buy |
116,598
+113,153
| +3,285% | +$2.45M | ﹤0.01% | 1503 |
|
|
2022
Q2 | $97K | Sell |
3,445
-3,409
| -50% | -$96K | ﹤0.01% | 3480 |
|
|
2022
Q1 | $316K | Buy |
+6,854
| New | +$316K | ﹤0.01% | 3076 |
|